By Kemo Cham
An Ebola vaccine candidate which was tried in Guinea, Liberia and Sierra Leone has been found to provide 100 percent protection, raising hopes for a potential prevention of the deadly hemorrhagic fever disease, the World Health Organisation (WHO) announced Friday.
The experimental vaccine called rVSV ZEBOV was found to be effective against the virus in a trial in Guinea, details of the study published on the medical journal, the Lancet, earlier in the week show.